E

Entia Biosciences Inc
OTC:ERGO

Watchlist Manager
Entia Biosciences Inc
OTC:ERGO
Watchlist
Price: 0.0003 USD Market Closed
Market Cap: $10.1k

Operating Margin

-439.7%
Current
No historical data
Comparison unavailable

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-439.7%
=
Operating Income
$-1.2m
/
Revenue
$265.5k

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-439.7%
=
Operating Income
$-1.2m
/
Revenue
$265.5k

Peer Comparison

Country Company Market Cap Operating
Margin
US
Entia Biosciences Inc
OTC:ERGO
10.1k USD
Loading...
FR
L'Oreal SA
PAR:OR
204.9B EUR
Loading...
UK
Unilever PLC
LSE:ULVR
118.9B GBP
Loading...
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
5.7T INR
Loading...
UK
HALEON PLC
LSE:HLN
34.2B GBP
Loading...
US
Estee Lauder Companies Inc
NYSE:EL
42.4B USD
Loading...
DE
Beiersdorf AG
XETRA:BEI
21.4B EUR
Loading...
JP
Kao Corp
TSE:4452
2.8T JPY
Loading...
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
1.3T INR
Loading...
IN
Dabur India Ltd
NSE:DABUR
920.5B INR
Loading...
CA
Relevium Technologies Inc
XTSX:RLV
12.2B CAD
Loading...

Market Distribution

Lower than 91% of companies in the United States of America
Percentile
9th
Based on 14 112 companies
9th percentile
-439.7%
Low
-4 087 900% — -5.1%
Typical Range
-5.1% — 14.8%
High
14.8% — 1 032 600%
Distribution Statistics
the United States of America
Min -4 087 900%
30th Percentile -5.1%
Median 6%
70th Percentile 14.8%
Max 1 032 600%

Entia Biosciences Inc
Glance View

Market Cap
10.1k USD
Industry
Consumer products

Entia Biosciences, Inc. operates as a biotechnology company. The company is headquartered in Sherwood, Oregon. The company went IPO on 2007-11-01. The firm also develops and markets health-related nutraceuticals and cosmeceuticals. ErgoD2 is a pharmaceutical-grade organic compound created from whole foods that contain the micro-nutrients L-ergothioneine, an amino acid that has a transporter (SLC22A4) in every human being, and vitamin D2. ErgoD2 improves iron homeostasis and mitigates iron-related disorders presenting in anemia, chronic kidney disease and select neurodegenerative diseases. The firm's ErgoD2 formulations utilize organically cultivated specialty mushrooms available from various domestic and international suppliers. These mushroom-based products are generally regarded as safe (GRAS). The firm's market and scientific research has identified mushroom species and suppliers to provide the nutritional profiles for its ErgoD2 formulations.

ERGO Intrinsic Value
Not Available
E
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-439.7%
=
Operating Income
$-1.2m
/
Revenue
$265.5k
How has Operating Margin changed over time?

Over the last 3 years, Entia Biosciences Inc’s Operating Margin has increased from -852.1% to -439.7%. During this period, it reached a low of -852.1% on Dec 1, 2013 and a high of -269.8% on Dec 31, 2014.

Back to Top